Big Pharma Showdown: Novartis vs. AstraZeneca in Q1 2025 Profits and Emissions Cuts
In the first quarter of 2025, pharmaceutical giants Novartis and AstraZeneca posted impressive financial results. Both were driven by strong drug performance and strategic investments. At the same time, each firm made notable strides in reducing carbon emissions and pushing toward ambitious sustainability targets. This head-to-head comparison looks at their Q1 2025 financial performance and […]